---
title: Hypercarbic Respiratory Failure
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Hypercarbic Respiratory Failure #ðŸš§ æ–½å·¥ä¸­

### Hypercarbic Respiratory Failure

â€¢Â Â Â Definition: Respiratory failure due to alveolar hypoventilation â†’ ineffective carbon dioxide elimination

â€¢Â Â Â Pathophysiology: 1) Impaired respiratory drive (i.e., CNS cause) 2) Impaired neuromuscular strength 3) Increased load on respiratory system

â€¢Â Â Â Differential diagnosis by mechanism:

-Â Â Â **Impaired respiratory drive**

**â€¢**Â Â Â Brainstem injuries

**â€¢**Â Â Â Drug overdose (e.g., opiates, sedatives)

**â€¢**Â Â Â Severe hypothyroidism

-Â Â Â **Impaired neuromuscular strength**

**â€¢**Â Â Â Neuromuscular diseases (e.g., myasthenia gravis, amyotrophic lateral sclerosis, Guillain-BarrÃ© syndrome, multiple sclerosis)

**â€¢**Â Â Â Weakness of respiratory muscles (e.g., myopathy, fatigue from increased work of breathing, severe electrolyte derangement)

-Â Â Â **Increased load**

**â€¢**Â Â Â Increased resistive load: Bronchospasm (e.g., COPD, asthma)

**â€¢**Â Â Â Decreased compliance:

-Â Â Â Lung: Restrictive disease, auto-PEEP

-Â Â Â Chest wall: Chest wall skeletal disorder, obesity, pleural effusion, ascites/distension

**â€¢**Â Â Â Increased required minute ventilation: DKA, sepsis, pulmonary embolism

â€¢Â Â Â Physiologic response:

-Â Â Â Hyperventilate to increase alveolar ventilation and blow off more CO2

-Â Â Â Vicious cycle: â†‘PaCO2 â†’ decline in mental status â†’ reduction in ventilator drive â†’ further â†‘PaCO2

â€¢Â Â Â Physical exam: See physical exam under dyspnea above

â€¢Â Â Â Work-up:

-Â Â Â ABG or VBG, CBC, CMP, consider troponin, BNP

-Â Â Â CXR, ECG, cardiac and pulmonary point of care ultrasound (POCUS), consider Chest CT or CT-PE

-Â Â Â Consider PFTs, testing maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP), other testing based on clinical suspicion

â€¢Â Â Â Treatment:

-Â Â Â Identify and treat underlying cause

-Â Â Â Consider NIPPV if not contraindicated; best evidence for use in COPD exacerbations

